Browsing eNauka
Browsing by Author Tobias, Joshua
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2020 | Cross-Reactive Effects of Vaccines: Heterologous Immunity between Tetanus and Chlamydia![]() | Stojanović, Marijana | Article | 21M21 |
| 2024 | Final results of the phase II trial of HER-Vaxx, a B-cell peptide-based vaccine plus standard care of chemotherapy in patients with HER2-overexpressing advanced gastric cancer - (HERIZON)![]() | Tobias, Joshua; ...; Andric, Zoran G | Conference Paper | Mp. category will be shown later |
| 2023 | HERIZON: A phase 2 study of HER-Vaxx (IMU-131), a HER2t-argeting peptide vaccine plus SOC chemotherapy in patients with HER2+advanced stomach cancer - correlation of the antibody responses and clinical outcome | Tobias, Joshua; Kundi, Michael; Garner-Spitzer, E; Zielinski, Christoph; Maglakelidze, Marina; Andric, Zoran G
Nixon, B; Yavrom, S; Ede, NJ; Wiedermann, Ursula;
| Conference Paper | Mp. category will be shown later |
| 2023 | HERIZON: A phase II study of HER-Vaxx (IMU-131), a HER2targeting peptide vaccine plus standard of care chemotherapy in patients with HER2+advanced stomach cancer - Dose-dependent anti-cancer antibodies correlating with improved clinical outcome | Tobias, Joshua; Kundi, Michael; Garner-Spitzer, E; Zielinski, Christoph; Maglakelidze, Marina; Andric, Zoran G
Nixon, B; Yavrom, S; Ede, NJ; Wiedermann, Ursula;
| Conference Paper | Mp. category will be shown later |
| 2024 | Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)![]() | Tobias, Joshua; ...; Andric, Zoran G | Article | 21a+M21a+ |
